-+ 0.00%
-+ 0.00%
-+ 0.00%

KAZIA THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PNOC035 CLINICAL STUDY EVALUATING PAXALISIB FOR RECURRENT PEDIATRIC AT/RT BRAIN CANCER

Reuters·09/09/2026 11:30:01

Please log in to view news